Telix Pharmaceuticals says it expects to report operating expenditure for the first half of 2025 that is 36% of the period’s ...

Telix Pharmaceuticals' share price (ASX:TLX) tumbled to a new 52-week low today, hitting A$16 as the firm faces up to headwinds including an SEC investigation and rising operational expenditure. The ...

The S&P/ASX 200 closed 106.7 points higher, up 1.23%. A wave of relief buying swept global markets today, sparked by expectations of lower interest rates in key jurisdictions. Despite the fact those ...

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

Greetings and welcome to HotCopper‘s Trends article for Tuesday 5th of August, running through the most popular announcements ...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down more than 18% on Tuesday. Here’s what you need to know.